✓Aug 31 session - Last update: Aug 31, 2026, 4:39 PM ET
⚡Material / Earnings✓High confidence
Source: daily_prices:fmp_change_percent
Changes History →Market closed · Next open: Tuesday 9:30 AM ET
Last update: Aug 31, 2026, 6:10 PM ETMarket closed·110 changes confirmed today
Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s
Investment research built around change detection.
Showing:
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
✓Aug 31 session - Last update: Aug 31, 2026, 4:53 PM ET
⚡Material / Earnings✓High confidence
What changed: Hinge Health, Inc. (HNGE) moved +6.54% from $86.88 to $92.56 on August 31, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor for HNGE earnings on November 3, 2026, to assess whether results support the price strength.
✓Aug 31 session - Last update: Aug 31, 2026, 4:48 PM ET
⚡Material / Earnings✓High confidence
What changed: Galaxy Digital (GLXY) moved +6.26% from $23.15 to $24.60 on 2026-08-31 after CEO Mike Novogratz and company leadership highlighted the firm's strategic pivot toward artificial intelligence (AI) data center infrastructure. Investors responded to Galaxy's transition into high-performance computing (HPC) and data center development at its Helios campus, moving beyond traditional crypto operations, while the stock trended as a top ticker on Stocktwits amid extremely bullish retail sentiment.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Galaxy Digital earnings are scheduled for 2026-10-20, with a consensus EPS estimate of –$0.05; watch for commentary on AI data center utilization rates and bookings.
✓Aug 31 session - Last update: Aug 31, 2026, 5:09 PM ET
⚡Material / Earnings✓High confidence
What changed: Ligand Pharmaceuticals Incorporated (LGND) moved +2.65% from $276.77 to $284.10 on 2026-08-31. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, indicating routine trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
LGND earnings are scheduled for 2026-11-05 with consensus EPS estimate of $2.62; results and forward guidance could provide directional catalysts.
✓Aug 31 session - Last update: Aug 31, 2026, 5:09 PM ET
⚡Material / Earnings✓High confidence
What changed: Chewy, Inc. (CHWY) moved +2.54% from $23.21 to $23.80 on 2026-08-31. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.5× the 5-day average, suggesting modest institutional interest ahead of the upcoming earnings report scheduled for 2026-09-02.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
CHWY earnings report on 2026-09-02 for the actual EPS result and management guidance.
✓Aug 31 session - Last update: Aug 31, 2026, 5:09 PM ET
⚡Material / Earnings✓High confidence
What changed: Vaxcyte, Inc. (PCVX) moved +2.77% from $59.10 to $60.74 on 2026-08-31. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.8x the 5-day average, suggesting modestly elevated trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
PCVX earnings scheduled for 2026-11-03 (consensus EPS estimate: $-2.12).
✓Aug 31 session - Last update: Aug 31, 2026, 5:08 PM ET
⚡Material / Earnings✓High confidence
What changed: Cipher Mining Inc. (CIFR) moved +2.51% from $15.12 to $15.50 on 2026-08-31. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, indicating routine trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor CIFR's earnings announcement on 2026-11-02 for actual results versus the −$0.31 EPS consensus.
✓Aug 31 session - Last update: Aug 31, 2026, 5:08 PM ET
🛡Material / Earnings✓High confidence
What changed: Aramark (ARMK) moved -2.71% from $57.88 to $56.31 on 2026-08-31. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was modestly elevated at 1.6x the 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Aramark's Q3 earnings on 2026-11-16 against the consensus EPS estimate of $0.76.
✓Aug 31 session - Last update: Aug 31, 2026, 5:08 PM ET
⚡Material / Earnings✓High confidence
What changed: Insmed Incorporated (INSM) moved +2.65% from $118.68 to $121.82 on 2026-08-31. We checked news, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.4x the 5-day average, indicating modestly elevated trading interest.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Insmed's Q3 2026 earnings announcement (2026-10-29) will be the next material event; consensus expects EPS of −$0.49.
✓Aug 31 session - Last update: Aug 31, 2026, 5:08 PM ET
⚡Material / Earnings✓High confidence
What changed: XPO Logistics, Inc. (XPO) moved +2.88% from $188.56 to $193.99 on August 31, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on modestly elevated volume (1.9x the 5-day average).
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
XPO earnings on 2026-10-29; consensus EPS estimate $1.56.
✓Aug 31 session - Last update: Aug 31, 2026, 5:08 PM ET
🛡Material / Earnings✓High confidence
What changed: Expedia Group, Inc. (EXPE) moved -2.50% from $325.24 to $317.12 on 2026-08-31. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
EXPE earnings are scheduled for 2026-11-05 with a consensus EPS estimate of $8.46.
✓Aug 31 session - Last update: Aug 31, 2026, 4:53 PM ET
🛡Material / Earnings✓High confidence
What changed: Janus Living, Inc. (JAN) moved -3.60% from $30.86 to $29.75 on 2026-08-31. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 2.3x the 5-day average, suggesting elevated trading activity ahead of the company's earnings announcement scheduled for 2026-09-02.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Janus Living earnings announcement on 2026-09-02 (consensus EPS estimate $0.05).
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.
ConsumerAugust 31, 2026 · 10 min read
Burlington (BURL) Stock Falls ~5% as Q3 Outlook Overshadows Q2 Beat
Burlington Stores fell about 4.8% to around $259.76 intraday on August 31, its third straight decline since the August 27 fiscal Q2 report (down ~7.6% on the 27th and ~5.9% on the 28th). The headline looked strong — reported adjusted EPS of $2.96, roughly 35% above consensus, with margin expansion and a 15th straight quarter of double-digit EPS growth — but the market looked past it. Comparable-store sales grew just 2% (down from 5% a year earlier), revenue narrowly missed at ~$3.00 billion, and Burlington guided third-quarter margins and EPS lower as it reinvests a $55 million tariff refund into customer prices. That refund also flattered the headline beat: Burlington's cleaner adjusted EPS ex-refund was $2.37 (still +38% year over year). Even though it raised full-year EPS guidance to $11.77–$11.97, a stock at ~23x earnings could not sustain a 2% comp and softer near-term margins, and Monday's leg down came as Goldman Sachs and Deutsche Bank cut targets. The move was company-specific: off-price peers Ross Stores and TJX fell less than 1% the same day. The stock is now deeply oversold (down ~31% from its high), yet 18 analysts keep a Buy consensus and a ~$365 average target.
BURLRead →
HealthcareAugust 31, 2026 · 11 min read
Cytokinetics (CYTK) Stock Falls Despite a Positive Phase 3 Aficamten Win
Cytokinetics fell about 7.5% on Friday and another ~3% Monday (to roughly $70) even though its pivotal Phase 3 ACACIA-HCM trial of aficamten met its goals in non-obstructive hypertrophic cardiomyopathy. The full data, presented at the ESC 2026 congress, hit both primary endpoints (symptoms and exercise capacity) — but the positive topline had been known since May, the stock had nearly doubled over the year, and the details disappointed: a modest effect size, two secondary endpoints that missed significance, and reduced ejection fraction (below-50% in ~10.5% of patients versus 0.8%; a known, reversible class effect). With a supplemental FDA filing not due until Q4 2026, revenue is years off, so investors sold. CYTK underperformed a soft biotech tape. Still, the Street stayed bullish: across 22 analysts, 20 rate CYTK a buy-equivalent, with an average target near $110 (about 57% above the price). Aficamten, already sold as Myqorzo for obstructive HCM, would expand into a large new patient group if the data carries through — the debate is about the details and the timeline, not whether the drug works.
CYTKRead →
TechnologyAugust 31, 2026 · 10 min read
Pinterest (PINS) Stock Falls 6% After CFO Julia Donnelly Resigns
Pinterest fell about 6% to around $21.73 on August 31 after disclosing that CFO Julia Brau Donnelly is resigning to join a private, early-stage company. She will stay until October 30 for an orderly transition, with a finance executive named interim CFO and an external search underway; the company said the exit is not due to any disagreement. Still, losing a CFO whose tenure the CEO credited with 11 straight quarters of double-digit revenue growth rattled a stock already down ~41% over the past year and trading at just ~11x forward earnings. The move was company-specific: the same day, ad peers Snap and The Trade Desk actually rose, while Meta and Alphabet fell only modestly. Analysts are constructive but split — a Buy consensus with a ~$29 average target, yet a cluster of Holds near the price — leaving the CFO exit to reopen, rather than settle, the debate over whether Pinterest's growth story holds.
PINSRead →
UtilitiesAugust 28, 2026 · 10 min read
PG&E (PCG) Stock Falls 7.5% as California Lawmakers Block a Wildfire-Liability Plan
PG&E fell 7.52% to $16.60 on August 28 — down as much as 12% intraday on nearly four times its average volume — after California lawmakers blocked a wildfire-liability reform. In closed-door talks that broke down late on August 27, days before the August 31 legislative deadline, lawmakers derailed Governor Newsom's push to eliminate or sharply curtail 'subrogation,' the process that lets insurers recover wildfire losses from utilities. That revived the catastrophic-liability fear from the 2017–2018 fires that forced PG&E into bankruptcy in early 2019. The move was a wildfire-exposure sell-off, not a sector one: Edison International fell nearly 5%, while diversified Sempra and the broad utilities ETF barely moved. PG&E trades at only ~10x forward earnings — a steep discount to the ~17–18x of the broader U.S. utilities sector — precisely because of this tail risk. Analysts, whose Buy consensus and ~$22.72 average target pre-date the vote, see 37% upside if the tail stays dormant; the market's $16.60 price reflects the risk it just repriced.
PCGRead →
TechnologyAugust 28, 2026 · 10 min read
Rubrik (RBRK) Stock Falls 13% Despite a Q2 Earnings Beat-and-Raise
Rubrik fell 13.05% to $93.05 on August 28 after reporting fiscal Q2 2027 results — even though the quarter was a clear beat-and-raise. Revenue rose about 38% to $427 million, non-GAAP EPS of $0.20 crushed the ~$0.04 estimate, subscription ARR reached $1.66 billion (up 33%), and management raised full-year guidance across revenue, ARR, free cash flow and profit. The stock fell anyway because it had surged about 48% during August to near its 52-week high on roughly 14 times sales — so a strong beat still wasn't the blow-out the price demanded, a classic 'sell-the-news' valuation reset (subscription ARR growth actually held roughly steady at 33%, and Q3 guidance beat). The Street read it as an entry, not an exit: as the shares dropped, Citi raised its target to $130 and Roth MKM to $120, and the Street kept a Strong Buy consensus near $116. The debate is about the multiple, not the business — a fast-growing, ~80%-gross-margin, cyber-resilience leader that is now profitable on an adjusted basis but still lossmaking on GAAP.
RBRKRead →
FinancialsAugust 28, 2026 · 10 min read
PayPal (PYPL) Stock Drops ~13% as Stripe-Advent Abandon a $53B Buyout Bid
PayPal fell about 12.5% to roughly $53.75 on August 28 after Bloomberg reported that the Stripe and Advent International consortium abandoned its pursuit of the company. The group had bid $60.50 a share (more than $53 billion) in mid-July — an offer PayPal's board reportedly deemed too low — and the stock had traded above the bid on expectations of a higher offer. With the buyers gone, the takeover premium round-tripped: PayPal fell back to its 50-day average, below the very price it had turned down. The debate now is whether the board saved value or squandered it: KBW's Sanjay Sakhrani kept Outperform at $70, while Mizuho's Dan Dolev cut to $51. Underneath the deal drama, PayPal is a cheap (~10x earnings), profitable, but out-of-favor fintech — down ~23% over the past year, rated Hold — that must now prove its case without an acquirer to settle it.
PYPLRead →